Covance to Acquire Merck's Gene Expression Lab | GenomeWeb

NEW YORK (GenomeWeb News) – Clinical research organization Covance said after the close of the market on Wednesday that it will acquire Merck's Seattle-based gene expression laboratory.

Although the Princeton, NJ-based firm did not disclose the price of the acquisition, it said that Merck had committed to a five-year genomic analysis services contract worth $145 million as part of the deal. The lab performs genotyping, gene sequencing, and gene expression profiling services. The firms did not provide revenue figures for the lab.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.